---
title: "Organogenesis enters $75 million at-the-market equity sales agreement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295151249.md"
description: "Organogenesis Holdings Inc. has entered into an at-the-market equity distribution agreement to sell up to $75 million of its Class A common stock. BTIG, LLC and Citizens JMP Securities are acting as sales agents for the offering. Shares may be sold periodically on Nasdaq or other markets per company instructions, with agents receiving commissions of up to 3% of gross proceeds."
datetime: "2026-08-06T22:15:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295151249.md)
  - [en](https://longbridge.com/en/news/295151249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295151249.md)
generator: "portal-rs"
---

# Organogenesis enters $75 million at-the-market equity sales agreement

-   Organogenesis entered an at-the-market equity distribution agreement to sell up to USD 75 million of Class A common stock. \* BTIG, LLC and Citizens JMP Securities will act as sales agents for the offering. \* Shares may be sold from time to time on Nasdaq or other trading markets, subject to company instructions. \* Agents will receive commissions of up to 3% of gross sales proceeds. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organogenesis Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-338321), on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ORGO.US](https://longbridge.com/en/quote/ORGO.US.md)

## Related News & Research

- [Organogenesis says FDA accepts ReNu biologics license application for knee osteoarthritis therapy](https://longbridge.com/en/news/291839384.md)
- [Organogenesis says RCT shows Affinity lifts venous leg ulcer closure rates at weeks 12 and 16](https://longbridge.com/en/news/293969176.md)
- [TestMu AI lance le « Cycle de vie de l'assurance » dans Kane CLI, transformant les documents d'exigences en couverture de test vérifiable](https://longbridge.com/en/news/299148825.md)
- [BOFH: Oh no! The CMS ate 500 pages of corporate documentation](https://longbridge.com/en/news/298702240.md)
- [NTUC members can get free entry to Sentosa every month](https://longbridge.com/en/news/299177536.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**